Medpal AI PLC
MPAL · AIM · Health Care · mcap £54m · 6.1p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 09 Oct 26 | Circular and Notice of General Meeting
Further to its announcement of 6 October 2026, MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-native digital health and pharmacy group, announces that a shareholder circular convening a General Meeting has been posted on th |
+1.7% | |
| 08 Oct 26 | Trading update | Trading Update
Record daily prescription orders of 2,300 on 5 October; £8m working capital facility indicative term sheet received; £6.4m cash position. |
+3.8% |
| 06 Oct 26 | September Update and Circular to Shareholders
September revenue reached £3.2m annualised run rate £38m, repeat orders now £1m monthly, GLP-1 expansion on track. |
−13.4% | |
| 11 Sep 26 | Exercise of Warrants
MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-powered, integrated digital health and pharmacy company, announces that the Company has received a notice to exercise warrants over a total of 4,130,833 new ordinary shares of |
−3.8% | |
| 09 Sep 26 | Board change | Board Change and Issue of Options
Harvey Sinclair appointed as independent Non-executive Director; 40m options granted to CEO Jason Drummond. |
−5.4% |
| 07 Sep 26 | Trading update | August Trading Update
New Health revenue reached £1.8m in August, first full month; Group annualised run rate now approximately £28m. |
+15.4% |
| 04 Sep 26 | Completion of eMARx Acquisition-Issue of Equity
Final Consideration for eMARx, Issue of Equity and Total Voting Rights |
−5.5% | |
| 01 Sep 26 | FDA Approval of Mounjaro for Heart Protection
FDA approves Mounjaro for cardiovascular protection in type 2 diabetes, expanding GLP-1 market beyond weight loss. |
+1.1% | |
| 11 Aug 26 | UK Authorises Eli Lilly's Once Daily GLP-1 Pill
UK becomes first European country to authorise Eli Lilly's once-daily oral GLP-1 tablet orforglipron for weight loss. |
+3.2% | |
| 04 Aug 26 | Trading update | July Trading Update
Annualised revenue run rate reached £8.6m across three revenue streams, up 70% in two months. |
+11.3% |
| 20 Jul 26 | Acquisition of eMARx
MedPal acquires eMARx, a UK care home medication administration software provider, completing its Health OS platform. |
+2.9% | |
| 03 Jul 26 | Fundraise | Placing to raise £5m
Medpal AI raises £5m via placing at 3.5p per share to fund Solid State Technologies acquisition and oral Wegovy launch. |
−8.7% |
| 01 Jul 26 | Approval of New Dispensing Facility
Opened Sarus Court, a 23,000 sq ft robotic pharmacy dispensing facility in Runcorn with NHS approval. |
+5.0% | |
| 18 Jun 26 | Launch of Juno, MedPal's AI Health Companion
MedPal AI launches Juno, an agentic AI health companion powered by Anthropic's Claude models and DigitalOcean infrastructure. |
+1.3% | |
| 12 Jun 26 | Approval of First Oral GLP-1 for Weight Loss in UK
MHRA approves first oral GLP-1 for weight loss in UK, creating opportunity for MedPal's New Health clinic. |
+33.9% | |
| 10 Jun 26 | Launch of new.co.uk Marketing Campaign
Commercial Update: new.co.uk Marketing Campaign Launch and Positioning Ahead of Anticipated UK Oral GLP-1 Availability |
−6.5% | |
| 01 Jun 26 | Pharmacy Operational Update
Record Monthly Dispensing Volume - Best Month Since Launch |
+10.0% | |
| 29 May 26 | Results | Half-year Results
Interim Results for the six months ended 28 February 2026 |
+2.0% |
| 20 May 26 | Launch of New Health dedicated GLP/peptides brand
Launch of New Health on new.co.uk as dedicated GLP-1 and peptides brand |
+4.2% | |
| 29 Apr 26 | Acquisition of Remedi Pharmacy Assets
Pathway to pharmacy EBITDA breakeven at 80,000 items per month |
+0.8% | |
| 20 Apr 26 | Issue of Fee Shares
MedPal AI Plc (AIM: MPAL, FRA: Z1N), the UK digital health and AI company, announces that it has issued 3,600,000 new ordinary shares ("Fee Shares") in lieu of £90,000 of cash in respect of advisory fees incurred by the |
−12.4% | |
| 17 Apr 26 | Fundraise | Placing to raise £3m
MedPal AI Plc (AIM: MPAL, FRA: Z1N), the UK digital health and AI company, is pleased to announce that it has conditionally raised gross proceeds of £3 million (the "Placing") through the issue of 120,000,000 new ordinar |
−8.7% |
| 08 Apr 26 | Updated Research Note
MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to announce the release of an updated research note by Optimo Research, alongside a new investor interview with CEO Jason Dru |
+12.0% | |
| 08 Apr 26 | Launch of MedPal Health OS
MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to provide an update on its technology platform strategy and the launch of the MedPal Health Operating System ("OS"). |
+12.0% | |
| 07 Apr 26 | Pharmacy Operational Update
MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to announce a record month of pharmacy dispensing activity at its wholly owned subsidiary, MedPal Limited. |
+31.6% | |
| 25 Mar 26 | Fundraise | Result of WRAP Retail Offer
Further to its announcement of 20 March 2026, MedPal AI plc (AIM: MPAL, FRA:Z1N), the UK digital health and AI company, is pleased to confirm the result of its WRAP Retail Offer ("WRAP"). |
−2.3% |
| 20 Mar 26 | Fundraise | WRAP Retail Offer
MedPal AI plc (AIM: MPAL), the digital health platform, is pleased to announce that it is undertaking a retail offer via the Winterflood Retail Access Platform ("WRAP") to raise up to £200,000 (the "WRAP Retail Offer") t |
+0.9% |
| 20 Mar 26 | Fundraise | Placing and WRAP Retail Offer
MedPal AI (AIM: MPAL, FRA: Z1N) the UK digital health and AI company, is pleased to announce that it has conditionally raised approximately £527,000 ("Placing") by way of the issue of 21,080,000 new ordinary shares ("Pla |
+0.9% |
| 20 Mar 26 | MedPal Enters At-Home Blood Testing Market
MedPal AI (AIM: MPAL, FRA: Z1N), the UK digital health and AI company, today announces its entry into the at-home blood testing market with the launch of the MedPal weight loss blood test. |
+0.9% | |
| 16 Mar 26 | Pharmacy Operational Update
MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to provide an operational update on pharmacy dispensing volumes at its wholly-owned subsidiary, MedPal Limited. |
+8.7% | |
| 27 Feb 26 | Results | Final Results
Final Results for the year ended 31 August 2025 |
−7.9% |
| 25 Feb 26 | Update and close of ATM
The Company has raised further gross proceeds of approximately £303,355.50 via the ATM facility through the issue of 6,055,000 new ordinary shares ("ATM Shares") at an average price of approximately 5.01p per ATM Share. |
−2.4% | |
| 16 Feb 26 | Completion of Acquisition
Completion of Acquisition of Universal Pharmacy assets and Expansion of Robotic Distribution Facility in Swaffham |
−7.1% | |
| 12 Feb 26 | Result of ATM - replacement
This announcement replaces announcement no.6641S 'Update on ATM Facility' released on 11 February 2026. |
−0.9% | |
| 11 Feb 26 | Update on ATM Facility
The Company has raised further gross proceeds of approximately £467,640 via the ATM facility through the issue of 9,000,000 new ordinary shares ("ATM Shares") at an average price of approximately 5.20p per ATM Share. |
−1.9% | |
| 10 Feb 26 | Vertically Integrated Healthcare Model
Operational Update: Vertically Integrated UK Healthcare Platform and Multi-Channel Revenue Model |
+2.9% | |
| 05 Feb 26 | Pharmacy operations update
MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to announce the continued strong performance of automated pharmacy operations at its wholly-owned subsidiary, MedPal Limited. |
+4.9% | |
| 03 Feb 26 | Secondary Listing on Frankfurt Exchange
MedPal AI (AIM: MPAL, FRA: Z1N), a UK-based digital health and artificial intelligence ("AI") company focused on health and wellness management, is pleased to announce that the Company's ordinary shares have been admitte |
+4.7% | |
| 28 Jan 26 | Eli Lilly Supply Agreement
MedPal AI plc (AIM: MPAL), the AI-powered digital health company, is pleased to announce that MedPal Limited, its wholly owned subsidiary, has been approved as an authorised purchaser of Eli Lilly pharmaceutical products |
+7.1% | |
| 26 Jan 26 | Result of ATM
The Company has raised further gross proceeds of approximately £339,560 via the ATM facility through the issue of 6,500,000 new ordinary shares ("ATM Shares") at an average price of approximately 5.22p per ATM Share. |
+0.0% | |
| 22 Jan 26 | Operational Efficiency Gains in Pharmacy
MedPal AI plc (AIM: MPAL), the digital health and AI company, is pleased to announce that, following recent technology infrastructure upgrades, it has achieved a substantial improvement in dispensing efficiency within it |
+0.0% | |
| 16 Jan 26 | Update on ATM Facility
The Company has raised further gross proceeds of approximately £378,870 via the ATM facility through the issue of 6,200,000 new ordinary shares ("ATM Shares") at an average price of 6.11p per ATM Share. |
+0.0% | |
| 08 Jan 26 | AI Integration with MedPal Clinic
MedPal AI (AIM: MPAL), a UK-based digital health and artificial intelligence ("AI") company, is pleased to announce the launch of what the Directors believe to be a UK-first: direct AI integration between a consumer heal |
+3.9% | |
| 05 Jan 26 | Trading update | Trading Update
FDA Approves First Oral GLP-1 for Weight Loss |
+35.0% |
| 16 Dec 25 | Update on ATM Facility
The Company has raised gross proceeds of approximately £498,225 via the ATM facility through the issue of 7,500,000 new ordinary shares ("ATM Shares") at an average price of 6.643p per ATM Share. |
−5.6% | |
| 09 Dec 25 | Board change | CEO Interview on Vox Markets
MedPal AI plc (AIM: MPAL), the UK-based digital health and artificial intelligence company, is pleased to announce the publication of a feature interview with Chief Executive Officer Jason Drummond on Vox Markets, one of |
−5.2% |
| 08 Dec 25 | App Update and Rollout to Epassi UK Gym Network
Major App Update and Rollout to Epassi UK Gym Network |
+0.0% | |
| 04 Dec 25 | Trading update | Trading Update and At The Market Facility
MedPal AI (AIM: MPAL), a UK-based digital health and artificial intelligence ("AI") company focused on health and wellness management, is pleased to provide a trading update on its pharmacy operations for November 2025 a |
+16.0% |
| 10 Nov 25 | NHS Approval & Operational Update
MedPal AI (AIM: MPAL), a UK-based digital health and artificial intelligence ("AI") company focused on health and wellness management, is pleased to announce that its wholly owned subsidiary, MedPal Limited, has received |
+13.8% | |
| 07 Nov 25 | Launch of MedPal Clinic Pharmacy Platform
Launch of MedPal.clinic: UK's First AI-Powered, Multimodal Pharmacy Platform |
+7.4% | |
| 03 Nov 25 | Initiation of research
MedPal AI plc (AIM:MPAL), a UK-based digital health and artificial intelligence (AI) company is pleased to announce the initiation of research by Optimo Capital Limited's research arm, Optimo Research Ltd ("Optimo Resear |
+2.9% | |
| 22 Oct 25 | Opening of AI-powered National Distribution Centre
Further to its announcement on 1 October 2025 regarding the acquisition of key assets from Universal Pharmacy Limited (in administration) ("Universal"), Medpal (AIM:MPAL), is pleased to announce the opening of a distribu |
+2.9% |
Company filings. Not investment advice.